Company News Summary | 30 Sep 2021

Click the print icon in your browser to print this report. Currency is in AUD unless otherwise specified

BWX Announces Completion of Acquisition of Stake in Go-To Skincare

13:44:00 | Associate analysts

Original annuncemenet:Completion of Acquisition of Stake in Go-To Skincare

BWX announced the completion of the Company's acquisition of a 50.1% interest in Go-To Skincare ("Go-To") for A$89m ("Acquisition Price") (the "Partnership"), which remained subject to customary post completion working capital adjustments. Founded by Zoe Foster Blake in 2014, Go-To is an Australian skin care provider with a range of skin care products for the masstige market. The Partnership is expected to be mid-single digit EPS accumulative on a FY21 pro forma basis (pre-synergies) and double-digit EPS accumulative on a FY21 pro forma basis post $3m of synergies in the first full financial year of the Partnership.

This report appeared on 2022 Morningstar Australasia Pty Limited

© Copyright 2022 Morningstar Australasia Pty Ltd ABN: 95 090 665 544 ("Morningstar"), AFSL no 240892. (a subsidiary of Morningstar, Inc.). This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Some of the material provided is published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO").

DISCLAIMER: To the extent that any of the content above constitutes advice, it is general advice that has been prepared without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain appropriate financial, legal and taxation advice before making any financial investment decision. If applicable, investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Please refer to our Financial Services Guide (FSG) for more information at FSG or phone Morningstar on 1800 03 44 55 to request a copy. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for any use or distribution of any of this information

DISCLOSURE: Employees may have an interest in the securities discussed in this report.